Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06519955 · ClinicalTrials.gov registry record · Phase 2
Can PLIA Reduce Early Post-operative Pain After PAO Surgery?
A Phase 2 study of Hip Dysplasia, sponsored by Michael C Willey.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT06519955: Recruiting Phase 2 study of Hip Dysplasia, sponsored by Michael C Willey.
NCT06519955 is a Phase 2 study of Hip Dysplasia that is actively recruiting participants, run by Michael C Willey. The registered enrollment target is 120 participants, below the 183-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (34% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06519955, a Phase 2 study of Hip Dysplasia, is actively recruiting participants, sponsored by Michael C Willey.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are: 1. Does PLIA impact post-operative pain after PAO? 2. Does PLIA impact pain medication usage as measured by morphine equivalent dosing (MED) after PAO? 3. Does the timing of PLIA administration impact post-operative pain and MED after PAO? Participants will be asked to complete some surveys; demographics survey, General Self-Efficacy Scale (GSE) and the Pain Resilience Scale. All other information will be gathered from the patients medical chart. Researchers will compare three groups. 1.) Patients who do not receive PLIA. 2.) Patients who receive PLIA after their incision is closed. 3.) Patients who receive PLIA throughout PAO.
Primary Outcome
Severity of pain will be measured by collection of the visual analog scale (VAS) for pain. Scale of 1-10.
Conditions Studied
Interventions
- COMBINATION_PRODUCT Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline)
Study Locations (1)
Iowa
- University of Iowa Health Care - Iowa City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2024-10-03 |
| Est. Completion | 2026-09 |
| Phase | Phase 2 |
What NCT06519955 shows while recruiting
NCT06519955 is an interventional study that assigns participants to a tested intervention. The registered 120 participants enrollment target is mid-sized for trials with a published cap, below the 183-participant average among 5 other Hip Dysplasia trials with a reported enrollment target (34% lower).
The record links to 1 condition, with Hip Dysplasia appearing as the primary indexed condition, and to 1 intervention - of which Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) is the first listed.
NCT06519955 reports a single indexed study location in Iowa.
Frequently Asked Questions
What is clinical trial NCT06519955 about?
NCT06519955 is a clinical study titled "Can PLIA Reduce Early Post-operative Pain After PAO Surgery?". The goal of this clinical trial is to compare different peri-incisional local infiltrative anesthesia (PLIA) methods in patients ages 13 to 50 undergoing a periacetabular osteotomy (PAO). The main questions to answer here are: 1. Does PLIA impact post-operative pain after PAO? 2. Does PLIA impact p...
What is the current status of trial NCT06519955?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2024-10-03. Estimated completion is 2026-09.
What conditions does trial NCT06519955 study?
This clinical trial studies the following conditions: Hip Dysplasia.
What interventions are being tested in trial NCT06519955?
The interventions under investigation include: Ropivacaine, Epinephrine, Ketorolac, NaCl (Saline) (COMBINATION_PRODUCT).
Who is sponsoring clinical trial NCT06519955?
This trial is sponsored by Michael C Willey, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06519955 being conducted?
This trial has 1 study location across Iowa. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hip Dysplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pain Injection Versus Epidural Anesthesia for Hip Surgery in Pediatric Patients With Cerebral Palsy
RECRUITING · Phase 4
-
Early Feasibility Study of Cartilage Defect Repair
RECRUITING · NA
-
Clinical Trial of Concomitant Hip Arthroscopy During PAO
RECRUITING · NA
-
Periacetabular Osteotomy With and Without Arthroscopic Management of Central Compartment Pathology
RECRUITING · NA
-
Mixed-Methods Evaluation of Short-, Medium-, and Long-Term Outcomes Following Hip Treatment
ACTIVE NOT RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01174108 · 120 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplantation for Severe Aplastic Anemia and Other Bone Marrow Failure Syndromes Using G-CSF Mobilized CD34+ Selected Hematopoietic Precursor Cells Co-Infused With a Reduced Dose of Non-Mobilized Donor T-cells
- NCT01627301 · 120 participants · NA
Sympathetic Overactivity in Post-traumatic Stress Disorder
- NCT02025023 · 120 participants · Phase 3
Local 5-Fluorouracil Injection for the Treatment of Chalazia: A Prospective, Comparative Study
- NCT02128906 · 120 participants · Phase 2
Radiotherapy With Cisplatin vs. Docetaxel-cetuximab in HNSCC: ERCC1 Biomarker Enrichment and Interaction Design
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI